Nightingale Health Plc has entered into an agreement in which it will analyze blood samples from Uganda's General Population Cohort (GPC). The GPC is a population-based study of approximately 22,000 individuals residing in southwestern Uganda. The study represents ten ethnolinguistic groupings and is the first from the region to be analyzed by Nightingale Health's technology.

It has been widely suggested that ethnic differences play a role in the development of chronic diseases due to genetic background. However, environmental exposures, such as diet, which can be comprehensively measured with Nightingale Health's metabolic biomarkers may play an even more significant role when it comes to the development of multiple different diseases. During the past years Nightingale Health has been chosen as an analysis service provider for various studies with different ethnicities.

Examples of such studies include the Singapore Multiethnic Cohort, China Kadoorie Biobank, and Mexico City Prospective Study. With this agreement Nightingale Health expands the use of its analysis technology to a new continent.